You may never have heard of sepsis. Meagan McLain hadn’t. But it nearly took the life of the University of Central Oklahoma student. If not for a drug called Xigris developed from discoveries made at OMRF, Meagan would have died of sepsis at age 21. The disease occurs when the body’s infection-fighting mechanism goes into overdrive, making the blood-clotting system malfunction and organ systems fail. A commonplace infection went out of control in Meagan’s bloodstream, and doctors raced to get ahead of her disease. She can’t remember specifics of her battle with sepsis, because she was unconscious for two weeks. Still, Meagan knows she’s lucky to be alive. She tells her story here.